Evidence map›Paper›PMID 39521254›Full record

Observational studyThe Journal of infection2024

Etiologies and comorbidities of meningitis deaths in children under 5 years in high-mortality settings: Insights from the CHAMPS Network in the post-pneumococcal vaccine era.

Sana Mahtab, Zachary J Madewell, Vicky Baillie, Ziyaad Dangor, Sanjay G Lala, Nega Assefa, Mulu Berihun, Lola Madrid, Lemma Demissie Regassa, J Anthony G Scott and 30 more

Abstract readObservational Study
In one paragraph

Observational study in The Journal of infection, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors.

Sana MahtabSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: sana.mahtab@wits-vida.org.
Zachary J MadewellGlobal Health Center, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Vicky BaillieSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Ziyaad DangorSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Sanjay G LalaDepartment of Paediatrics & Child Health, Faculty of Health Sciences, University of the Witwatersrand, South Africa.
Nega AssefaCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Mulu BerihunCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Lola MadridCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Lemma Demissie RegassaCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
J Anthony G ScottDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Soter AmehCHAMPS Sierra Leone, Freetown, Sierra Leone.
Joseph S BanguraMinistry of Health and Sanitation, Freetown, Sierra Leone.
Okokon ItaUniversity of Calabar Teaching Hospital, Nigeria.
Erick KalumaCHAMPS Sierra Leone, Freetown, Sierra Leone.
Ikechukwu Udo OgbuanuCHAMPS Sierra Leone, Freetown, Sierra Leone.
Brigitte GaumeCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Karen L KotloffCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Samba O SowCentre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali.
Milagritos D TapiaCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Sara AjanovicCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique; ISGlobal, Barcelona, Spain, Facultat de Medicina i Ciències de la Salut, Unviersitat de Barcelona (UB), Barcelona, Spain.
Marcelino GarrineCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Inacio MandomandoCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique; ISGlobal, Barcelona, Spain, Facultat de Medicina i Ciències de la Salut, Unviersitat de Barcelona (UB), Barcelona, Spain; Instituto Nacional de Saúde, Ministério de Saúde, Maputo, Mozambique.
Rosauro VaroCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique; ISGlobal, Barcelona, Spain, Facultat de Medicina i Ciències de la Salut, Unviersitat de Barcelona (UB), Barcelona, Spain.
Elisio G XerindaCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Muntasir AlamInternational Centre for Diarrhoeal Disease Research Bangladesh (ICDDRB), Dhaka, Bangladesh.
Shams El ArifeenInternational Centre for Diarrhoeal Disease Research Bangladesh (ICDDRB), Dhaka, Bangladesh.
Emily S GurleyInternational Centre for Diarrhoeal Disease Research Bangladesh (ICDDRB), Dhaka, Bangladesh; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Mohammad Zahid HossainInternational Centre for Diarrhoeal Disease Research Bangladesh (ICDDRB), Dhaka, Bangladesh.
Afruna RahmanInternational Centre for Diarrhoeal Disease Research Bangladesh (ICDDRB), Dhaka, Bangladesh.
Victor AkeloCenters for Disease Control and Prevention-Kenya, Kisumu, Kenya.
Kitiezo Aggrey IgunzaKenya Medical Research Institute, Center for Global Health Research, Kisumu, Kenya.
Clayton OnyangoCenter for Global Health, US Centers for Disease Control and Prevention, Nairobi, Kenya.
Dickens OnyangoKisumu County Department of Health, Kisumu, Kenya.
Jennifer R VeraniNational Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Portia MutevedziEmory Global Health Institute, Emory University, Atlanta, GA, USA.
Cynthia G WhitneyEmory Global Health Institute, Emory University, Atlanta, GA, USA.
Dianna M BlauGlobal Health Center, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Shabir A MadhiSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Wits Infectious Diseases and Oncology Research Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Quique BassatCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique; ISGlobal, Barcelona, Spain, Facultat de Medicina i Ciències de la Salut, Unviersitat de Barcelona (UB), Barcelona, Spain; ICREA, Pg. Lluís Companys 23, 08010 Barcelona, Spain; Pediatrics Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Esplugues, Barcelona, Spain; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública-CIBERESP, Madrid, Spain.
CHAMPSconsortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe role of meningitis in causing deaths and in children under 5 is unclear, especially since widespread use of vaccines to prevent common causes of meningitis. Child Health and Mortality Prevention Surveillance (CHAMPS) uses post-mortem minimally invasive tissue sampling (MITS) and ante-mortem data to explore death causes. We aimed to assess meningitis's contribution to mortality and identify causative pathogens in children under 5 within CHAMPS Network sites.

methodIn this observational study, we analyzed deaths in live-born children <5 years of age that occurred between December 16, 2016, and December 31, 2023, in CHAMPS catchments in six sub-Saharan African countries (Ethiopia, Kenya, Mali, Mozambique, Sierra Leone, South Africa) and Bangladesh. MITS was conducted within 24-72 h of death, including blood and cerebrospinal fluid (CSF) culture, multi-organism targeted nucleic acid amplification tests on blood, CSF and lung tissue, and histopathology of lung, liver and brain. Expert panels at each site reviewed data to attribute causes of death following ICD-10 standards.

resultMeningitis was in the causal pathway for 7.0% (270/3857) of deaths; in 4.8% (13/270) meningitis was considered the underlying condition. Neonates accounted for 65.9% (178/270) and infants or children 34.1% (92/270). Among neonatal meningitis deaths, 55.6% (99/178) occurred ≥72 h post-hospital admission; and common pathogens were Acinetobacter baumannii (49.5%, 49/99; mainly from South Africa) and Klebsiella pneumoniae (40.4%, 40/99). Forty-four percent (79/178) of neonatal meningitis deaths were community-associated, primarily due to K. pneumoniae (35.4%, 28/79) and Escherichia coli (13.9%, 11/79). Among infant and child meningitis deaths, 43.5% (40/92) occurred ≥72 h post-admission; and common pathogens were K. pneumoniae (42.5%,17/40) and A. baumannii (17.5%, 7/40). Among community-associated meningitis deaths in infants and children (56.5%, 52/92), Streptococcus pneumoniae (34.6%, 18/52) and K. pneumoniae (19.2%, 10/52) were common pathogens. Pathogen prevalence varied by region.

conclusionOur study highlights meningitis as a significant contributor to under-5 mortality in low-middle-income countries. The prominent role of K. pneumoniae and A. baumannii, particularly in healthcare settings and specific regions, highlights the need for better infection control, targeted interventions, and more effective treatment strategies.

Indexed as

Pneumococcal VaccinesAfrica South of the SaharaCause of DeathChild, PreschoolComorbidityFemaleHumansInfantInfant, NewbornMaleMeningitisMeningitis, BacterialPneumococcal VaccinesCommunity associated meningitisMeningitisMinimally invasive tissue samplingOccurred ≥72 h post-hospital admissionPathogens

Identifiers

PMID39521254
PMCPMC11624489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.